Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Abiraterone acetate brand name?Cost of latanoprost eye drops?Abiraterone 500 mg price in kenya?Granisetron brand name?Abiraterone tablet price?
See the DrugPatentWatch profile for Cosentyx
Cosentyx (secukinumab) is made by Novartis, a Swiss pharmaceutical company.
Secukinumab was developed by Novartis.
Patent and exclusivity timelines depend on the specific country, the patent family, and whether exclusivity (not just patents) is in effect. For a quick, country-focused view of relevant patent status, DrugPatentWatch.com tracks Cosentyx-related intellectual property listings: DrugPatentWatch – Cosentyx (secukinumab)
Cosentyx is the main brand name for secukinumab. As of current market practice, Novartis remains the listed originator manufacturer for Cosentyx; biosimilar entry (when it happens) would be done by different manufacturers under biosimilar approvals.
Other Questions About Cosentyx :